Who is sponsoring NCT03255889?

NCT03255889 is sponsored by National University Hospital, Singapore.

What condition does NCT03255889 study?

NCT03255889 studies Polycystic Ovary Syndrome.

What drugs are being tested in NCT03255889?

Interventions: Glyceryl Tridecanoate, Placebo.

What is the status of NCT03255889?

NCT03255889 is currently WITHDRAWN.

Last reviewed 2017-12-07 · How we verify

Absorption and Tolerability Studies of an Emulsion Containing the Coconut Oil-derived Glycerol Tridecanoate in Healthy Men

NCT03255889 PHASE1 WITHDRAWN

The primary aim of the study is to test safety and tolerance of oral intake of GT oil in the form of a non-diary based emulsion (10g of GT per emulsion) in healthy men. This will be a single center study, and the recruitment is expected to happen over a 1-2- month's period.

Details

Lead sponsor	National University Hospital, Singapore
Phase	PHASE1
Status	WITHDRAWN
Start date	Mon Aug 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Mar 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Polycystic Ovary Syndrome

Interventions

Glyceryl Tridecanoate
Placebo

Countries

Singapore